Clinical Trial Update: Study of Mepolizumab Autoinjector in Asthmatics [Phase 3]

View source ↗

Summary

Phase 3 study of a mepolizumab autoinjector in asthmatics has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• mepolizumab autoinjector (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-06-29